Radioisotope developer MDS Nordion of Kanata, ON, has started commercial production at its TR-30-2 cyclotron in Vancouver, BC. The unit, the third at the firm’s Vancouver site, is authorized by the Canadian Nuclear Safety Commission (CNSC) for production of medical isotopes. The new cyclotron will produce a broad range of medical isotopes, including I-123, Pd-103, Tl-201, and In-111, according to the company.
By AuntMinnie.com staff writersJune 17, 2003
Related Reading
MDS sells oncology software unit to Delft, February 11, 2003
MDS Nordion gets regulatory approvals, July 11, 2002
MDS Nordion focuses on oncology software solutions, June 28, 2002
Varian to buy MDS Nordion's brachytherapy unit, June 27, 2002
MDS expands manufacturing facilities, June 12, 2002
Copyright © 2003 AuntMinnie.com
